Navigation Links
CoreLab Partners, Medical Image Assessment Experts, Announces Its Entry Into the Early Alzheimer's Imaging Market Space
Date:12/6/2012

PRINCETON, N.J., Dec. 6, 2012 /PRNewswire/ -- CoreLab Partners, Inc., a leading independent core lab providing centralized cardiac safety services and medical imaging assessment, has launched new imaging capabilities targeted at the utilization of independent central image review in the detection of early Alzheimer's disease.

"Recognizing the ongoing evolution of magnetic resonance imaging (MRI), positron emission tomography (PET) and single-photon emission computed tomography (SPECT) imaging in dementia-related clinical trials, CoreLab Partners has put into place a team of knowledgeable experts combined with advanced technological tools to ensure current and emerging image assessment needs are met," stated Dr. Michael Woehler, President & CEO. "This exciting new capability is a natural extension of our industry-leading suite of imaging science solutions and marks a significant milestone in the utilization of scientifically validated tools designed to accurately quantify brain structure volumetric data," added Woehler.

Senior members of the CoreLab Partners' medical affairs team will be attending CBIs upcoming 6th Annual Alzheimer's Drug Development Summit to be held in Philadelphia, PA from December 11 – 12, 2012; please join us for this important industry event as the scientific community shares their future perspectives from the Dominantly Inherited Alzheimer's Network (DIAN).

About CoreLab Partners, Inc.

CoreLab Partners, with offices in North America, Europe and Asia, provides comprehensive medical image assessment and cardiac safety services to the pharmaceutical, biotechnology and medical device industries.  An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with board certified, sub-specialty trained Radiologists, Cardiologists, nuclear medicine physicians and Oncologists. CoreLab Partners delivers disciplined solutions for the collection, analysis and management of patient images and cardiac safety & efficacy information during drug development. Driven by best-in-class science, emerging technologies and service quality, CoreLabs is a global leader providing imaging sciences in all major modalities complemented by service offerings in the conduct of automated ECG, Thorough QT, Holter Monitoring, Ambulatory Blood Pressure Monitoring and Pulse Wave Analysis.

http://www.corelabpartners.com

Contact:

Daja Herald
Marketing Manager
Email: dherald@corelabpartners.com
Phone: 609-936-2600

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE CoreLab Partners, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. CoreLab Partners Opens Office in Tokyo, Japan
2. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
3. DiaTech Life Sciences Announces Medical Advisory Board
4. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
5. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
6. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
7. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
8. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
9. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
10. Live Press Briefing on Findings of Biomedical Industry CEO Survey
11. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Information Management Services ( ... The upgrade represents a completely new technical foundation and is so significant it ... responsive design interface, significantly increased speed for search results, a streamlined layout and a ...
(Date:2/8/2016)... Stockton has an active R&D program for the ... area, the Group has a unique research and development center ... in developing Bio Control products. Stockton ... parameters and regulatory guidelines, and is active in more than ... Stockton,s flagship product Timorex Gold ...
(Date:2/6/2016)... , ... February 06, 2016 , ... ... , The Center for Excellence in Education Sponsors Teacher Training Program , ... February 4, 2016 – The Center for Excellence in Education (CEE) will sponsor ...
(Date:2/5/2016)... 5, 2016 Amarantus BioScience Holdings, ... focused on developing products for Regenerative Medicine, Neurology and ... Disease Designation (RPDD) from the US Food and Drug ... MANF was previously granted orphan drug designation (ODD) by ... Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), ...
Breaking Biology Technology:
(Date:1/18/2016)... 2016  Extenua Inc., a pioneering developer of ... and access of ubiquitous on-premise and cloud storage, today ... Cyber.  ... C4ISR and Cyber initiatives in support of National ... technology solutions," said Steve Visconti , Extenua ...
(Date:1/13/2016)... , January 13, 2016 ... the addition of the  "India Biometrics ... & Forecast (2015-2020)"  report to ... ) has announced the addition of ... Market - Estimation & Forecast (2015-2020)" ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016   ... diagnostic products, today announced the closing of a $9 million ... Proceeds from the financing will be used to accelerate the ... for detecting early-stage pressure ulcers. United ... receiving CE Mark approval. The device,s introduction has been met ...
Breaking Biology News(10 mins):